

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | membrane tubulation (GO:0097320) | 7.89153028 |
| 2 | regulation of DNA damage checkpoint (GO:2000001) | 7.34795631 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.29062490 |
| 4 | intra-S DNA damage checkpoint (GO:0031573) | 6.96569902 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.77122848 |
| 6 | myoblast migration (GO:0051451) | 6.76965669 |
| 7 | macrophage activation involved in immune response (GO:0002281) | 6.64296579 |
| 8 | inner cell mass cell proliferation (GO:0001833) | 6.59376140 |
| 9 | microglial cell activation (GO:0001774) | 6.56470234 |
| 10 | phagocytosis, engulfment (GO:0006911) | 6.50045954 |
| 11 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 6.23524130 |
| 12 | heart trabecula morphogenesis (GO:0061384) | 6.20983398 |
| 13 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 6.15290707 |
| 14 | skeletal muscle tissue regeneration (GO:0043403) | 6.08034348 |
| 15 | complement activation, classical pathway (GO:0006958) | 5.96654615 |
| 16 | autophagic vacuole fusion (GO:0000046) | 5.87777819 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.85961460 |
| 18 | macrophage chemotaxis (GO:0048246) | 5.80267210 |
| 19 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 5.57697239 |
| 20 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 5.57697239 |
| 21 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 5.48965562 |
| 22 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.43881989 |
| 23 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 5.34848516 |
| 24 | defense response to Gram-negative bacterium (GO:0050829) | 5.21118798 |
| 25 | trabecula morphogenesis (GO:0061383) | 5.17909844 |
| 26 | behavioral response to nicotine (GO:0035095) | 5.10315823 |
| 27 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.98639566 |
| 28 | cellular response to gamma radiation (GO:0071480) | 4.95590655 |
| 29 | nucleoside diphosphate catabolic process (GO:0009134) | 4.84656939 |
| 30 | complement activation (GO:0006956) | 4.76589712 |
| 31 | organelle membrane fusion (GO:0090174) | 4.75654568 |
| 32 | cellular defense response (GO:0006968) | 4.62114776 |
| 33 | acyl-CoA biosynthetic process (GO:0071616) | 4.56617853 |
| 34 | thioester biosynthetic process (GO:0035384) | 4.56617853 |
| 35 | chemokine-mediated signaling pathway (GO:0070098) | 4.38072316 |
| 36 | positive regulation of skeletal muscle tissue development (GO:0048643) | 4.31643528 |
| 37 | regulation of cell cycle checkpoint (GO:1901976) | 4.16268232 |
| 38 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 4.15728958 |
| 39 | regulation of gene silencing (GO:0060968) | 4.11321248 |
| 40 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.10531353 |
| 41 | membrane invagination (GO:0010324) | 4.05423109 |
| 42 | regulation of mononuclear cell migration (GO:0071675) | 4.03500803 |
| 43 | regulation of macrophage chemotaxis (GO:0010758) | 3.99264793 |
| 44 | mitochondrial calcium ion transport (GO:0006851) | 3.90872822 |
| 45 | muscle cell migration (GO:0014812) | 3.82839236 |
| 46 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.76224696 |
| 47 | very long-chain fatty acid metabolic process (GO:0000038) | 3.74844965 |
| 48 | DNA damage response, detection of DNA damage (GO:0042769) | 3.68924882 |
| 49 | positive regulation of respiratory burst (GO:0060267) | 3.68687504 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 3.67412804 |
| 51 | response to pheromone (GO:0019236) | 3.65907772 |
| 52 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.63384531 |
| 53 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 3.53302740 |
| 54 | protein activation cascade (GO:0072376) | 3.48830111 |
| 55 | macrophage activation (GO:0042116) | 3.42022424 |
| 56 | cellular extravasation (GO:0045123) | 3.31370446 |
| 57 | regulation of transcription elongation from RNA polymerase II promoter (GO:0034243) | 3.13927296 |
| 58 | positive regulation of T cell chemotaxis (GO:0010820) | 3.09250976 |
| 59 | regulation of T cell chemotaxis (GO:0010819) | 3.09250976 |
| 60 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.06573992 |
| 61 | triglyceride biosynthetic process (GO:0019432) | 3.03148105 |
| 62 | regulation of heart morphogenesis (GO:2000826) | 2.99912048 |
| 63 | RNA methylation (GO:0001510) | 2.91573084 |
| 64 | dendritic cell chemotaxis (GO:0002407) | 2.91431503 |
| 65 | glomerular filtration (GO:0003094) | 2.87815994 |
| 66 | neutral lipid biosynthetic process (GO:0046460) | 2.87111420 |
| 67 | acylglycerol biosynthetic process (GO:0046463) | 2.87111420 |
| 68 | cellular response to interleukin-15 (GO:0071350) | 2.82910072 |
| 69 | humoral immune response (GO:0006959) | 2.82366601 |
| 70 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.80599864 |
| 71 | diol metabolic process (GO:0034311) | 2.80571087 |
| 72 | neutrophil activation involved in immune response (GO:0002283) | 2.77723090 |
| 73 | negative regulation of muscle cell apoptotic process (GO:0010656) | 2.77016603 |
| 74 | antibacterial humoral response (GO:0019731) | 2.75038304 |
| 75 | vesicle targeting (GO:0006903) | 2.72134971 |
| 76 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.71067497 |
| 77 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.68490954 |
| 78 | positive T cell selection (GO:0043368) | 2.67535080 |
| 79 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.66803799 |
| 80 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.66803799 |
| 81 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.66803799 |
| 82 | antimicrobial humoral response (GO:0019730) | 2.66711519 |
| 83 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.65670787 |
| 84 | regulation of G2/M transition of mitotic cell cycle (GO:0010389) | 2.64245480 |
| 85 | lymphocyte chemotaxis (GO:0048247) | 2.64123244 |
| 86 | germinal center formation (GO:0002467) | 2.63066726 |
| 87 | positive regulation of mitotic cell cycle phase transition (GO:1901992) | 2.58055150 |
| 88 | renal filtration (GO:0097205) | 2.55330522 |
| 89 | eosinophil chemotaxis (GO:0048245) | 2.54470449 |
| 90 | response to interleukin-15 (GO:0070672) | 2.52841823 |
| 91 | lymph node development (GO:0048535) | 2.52306034 |
| 92 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.49953595 |
| 93 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.49953595 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.48661608 |
| 95 | histone H4-K12 acetylation (GO:0043983) | 13.1707716 |
| 96 | fatty acid elongation (GO:0030497) | 12.5831219 |
| 97 | regulation of gene silencing by miRNA (GO:0060964) | 11.9931139 |
| 98 | regulation of gene silencing by RNA (GO:0060966) | 11.9931139 |
| 99 | regulation of posttranscriptional gene silencing (GO:0060147) | 11.9931139 |
| 100 | negative regulation of gene silencing (GO:0060969) | 10.6673139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.57337481 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 5.25491384 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.20912143 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.84962755 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.68502292 |
| 6 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 2.64689615 |
| 7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13764266 |
| 8 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.10784751 |
| 9 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.06510408 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98902283 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97136878 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.94710240 |
| 13 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.83601570 |
| 14 | GATA1_19941826_ChIP-Seq_K562_Human | 1.75813639 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74760942 |
| 16 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.72341308 |
| 17 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.66294979 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.65559291 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60743669 |
| 20 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.59272333 |
| 21 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.58634643 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57298503 |
| 23 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.49502597 |
| 24 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.49502597 |
| 25 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.49502597 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47773415 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.47388957 |
| 28 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.45752567 |
| 29 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45397027 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.45099298 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42761946 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42558492 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40474151 |
| 34 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.39999974 |
| 35 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.39197324 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38347015 |
| 37 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35117006 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35042576 |
| 39 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.32490953 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29739024 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28817948 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26451289 |
| 43 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.26444862 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25205867 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25177050 |
| 46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25176624 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25129554 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23799754 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23247762 |
| 50 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.22687741 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22242558 |
| 52 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.22209721 |
| 53 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20738476 |
| 54 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.20563098 |
| 55 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.19323672 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16361354 |
| 57 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15375740 |
| 58 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.14445286 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13602790 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11529274 |
| 61 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10898068 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10572799 |
| 63 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10150654 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09956514 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09503638 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09308954 |
| 67 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08955010 |
| 68 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08868528 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08704748 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08551425 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07919316 |
| 72 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07382888 |
| 73 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05446468 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04928353 |
| 75 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03786343 |
| 76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03643768 |
| 77 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02498014 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00582037 |
| 79 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97439930 |
| 80 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.96554955 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95037624 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94499376 |
| 83 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.93689229 |
| 84 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.93252965 |
| 85 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92964748 |
| 86 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.91780130 |
| 87 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.91523507 |
| 88 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.90504639 |
| 89 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.89668500 |
| 90 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89251427 |
| 91 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.88948299 |
| 92 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88521499 |
| 93 | MYB_26560356_Chip-Seq_TH2_Human | 0.87537462 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85831124 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.84908054 |
| 96 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.84507481 |
| 97 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83480163 |
| 98 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.82359529 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81236016 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81095803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 5.93903171 |
| 2 | MP0008260_abnormal_autophagy | 5.63905459 |
| 3 | MP0005671_abnormal_response_to | 4.24579082 |
| 4 | MP0001188_hyperpigmentation | 3.91284684 |
| 5 | MP0000685_abnormal_immune_system | 3.77574841 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 3.42997726 |
| 7 | MP0003567_abnormal_fetal_cardiomyocyte | 3.25452860 |
| 8 | MP0003724_increased_susceptibility_to | 3.16709789 |
| 9 | MP0000750_abnormal_muscle_regeneration | 3.15776982 |
| 10 | MP0005166_decreased_susceptibility_to | 3.11251845 |
| 11 | MP0003436_decreased_susceptibility_to | 3.08401596 |
| 12 | MP0009785_altered_susceptibility_to | 2.84232935 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.77916774 |
| 14 | MP0004883_abnormal_blood_vessel | 2.71469582 |
| 15 | MP0003690_abnormal_glial_cell | 2.49018124 |
| 16 | MP0001915_intracranial_hemorrhage | 2.33883281 |
| 17 | MP0005025_abnormal_response_to | 2.25133018 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.20823816 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.13725045 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.13521055 |
| 21 | MP0001243_abnormal_dermal_layer | 2.01514970 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.98015608 |
| 23 | MP0005164_abnormal_response_to | 1.91142705 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.90302295 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.89873621 |
| 26 | MP0002419_abnormal_innate_immunity | 1.88667705 |
| 27 | MP0005387_immune_system_phenotype | 1.73882736 |
| 28 | MP0001790_abnormal_immune_system | 1.73882736 |
| 29 | MP0003303_peritoneal_inflammation | 1.73547602 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.67730035 |
| 31 | MP0003279_aneurysm | 1.61862083 |
| 32 | MP0006054_spinal_hemorrhage | 1.53994830 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.43969079 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.41488050 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.37189073 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.37039913 |
| 37 | MP0001819_abnormal_immune_cell | 1.36919771 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.36738736 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.32862305 |
| 40 | MP0001800_abnormal_humoral_immune | 1.32630566 |
| 41 | MP0005670_abnormal_white_adipose | 1.27013431 |
| 42 | MP0004043_abnormal_pH_regulation | 1.25605375 |
| 43 | MP0002723_abnormal_immune_serum | 1.22677719 |
| 44 | MP0005197_abnormal_uvea_morphology | 1.19345821 |
| 45 | MP0003045_fibrosis | 1.14409575 |
| 46 | MP0003787_abnormal_imprinting | 1.05801344 |
| 47 | MP0005595_abnormal_vascular_smooth | 1.05436875 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.02500002 |
| 49 | MP0001845_abnormal_inflammatory_respons | 0.99497783 |
| 50 | MP0000920_abnormal_myelination | 0.95590636 |
| 51 | MP0010368_abnormal_lymphatic_system | 0.94554212 |
| 52 | MP0001727_abnormal_embryo_implantation | 0.92499177 |
| 53 | MP0009840_abnormal_foam_cell | 0.91424849 |
| 54 | MP0000249_abnormal_blood_vessel | 0.90662857 |
| 55 | MP0008873_increased_physiological_sensi | 0.90398656 |
| 56 | MP0000716_abnormal_immune_system | 0.87698230 |
| 57 | MP0003448_altered_tumor_morphology | 0.87199605 |
| 58 | MP0002896_abnormal_bone_mineralization | 0.86979096 |
| 59 | MP0004885_abnormal_endolymph | 0.85768329 |
| 60 | MP0002971_abnormal_brown_adipose | 0.84850694 |
| 61 | MP0000477_abnormal_intestine_morphology | 0.84606344 |
| 62 | MP0003866_abnormal_defecation | 0.84113712 |
| 63 | MP0005275_abnormal_skin_tensile | 0.81363318 |
| 64 | MP0005376_homeostasis/metabolism_phenot | 0.79515175 |
| 65 | MP0002998_abnormal_bone_remodeling | 0.78957536 |
| 66 | MP0000343_altered_response_to | 0.78042392 |
| 67 | MP0005083_abnormal_biliary_tract | 0.74448224 |
| 68 | MP0008004_abnormal_stomach_pH | 0.72299854 |
| 69 | MP0005023_abnormal_wound_healing | 0.71259655 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.69950781 |
| 71 | MP0009763_increased_sensitivity_to | 0.69807119 |
| 72 | MP0005390_skeleton_phenotype | 0.68586992 |
| 73 | MP0008469_abnormal_protein_level | 0.68241142 |
| 74 | MP0002876_abnormal_thyroid_physiology | 0.68173697 |
| 75 | MP0002139_abnormal_hepatobiliary_system | 0.67713016 |
| 76 | MP0001849_ear_inflammation | 0.67349303 |
| 77 | MP0002405_respiratory_system_inflammati | 0.66860941 |
| 78 | MP0002166_altered_tumor_susceptibility | 0.65379826 |
| 79 | MP0003795_abnormal_bone_structure | 0.65081535 |
| 80 | MP0005448_abnormal_energy_balance | 0.63174868 |
| 81 | MP0001666_abnormal_nutrient_absorption | 0.61664149 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.60897631 |
| 83 | MP0002118_abnormal_lipid_homeostasis | 0.60301225 |
| 84 | MP0002398_abnormal_bone_marrow | 0.59440355 |
| 85 | MP0005503_abnormal_tendon_morphology | 0.58044318 |
| 86 | MP0002697_abnormal_eye_size | 0.58016586 |
| 87 | MP0004084_abnormal_cardiac_muscle | 0.57937842 |
| 88 | MP0001663_abnormal_digestive_system | 0.57370191 |
| 89 | MP0005360_urolithiasis | 0.57287476 |
| 90 | MP0008875_abnormal_xenobiotic_pharmacok | 0.57215149 |
| 91 | MP0003252_abnormal_bile_duct | 0.56857540 |
| 92 | MP0005381_digestive/alimentary_phenotyp | 0.55695756 |
| 93 | MP0002429_abnormal_blood_cell | 0.55239993 |
| 94 | MP0001216_abnormal_epidermal_layer | 0.52985513 |
| 95 | MP0002933_joint_inflammation | 0.52930731 |
| 96 | MP0010386_abnormal_urinary_bladder | 0.52684726 |
| 97 | MP0005375_adipose_tissue_phenotype | 0.51092454 |
| 98 | MP0001664_abnormal_digestion | 0.49964961 |
| 99 | MP0000462_abnormal_digestive_system | 0.49436361 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.49425126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cortical dysplasia (HP:0002539) | 7.25341873 |
| 2 | Deep palmar crease (HP:0006191) | 6.93508932 |
| 3 | Scotoma (HP:0000575) | 5.91728135 |
| 4 | Prostate neoplasm (HP:0100787) | 5.89927627 |
| 5 | Hyperlipoproteinemia (HP:0010980) | 5.36766507 |
| 6 | Epidermoid cyst (HP:0200040) | 5.15571481 |
| 7 | Curly hair (HP:0002212) | 5.12075430 |
| 8 | Severe visual impairment (HP:0001141) | 4.85384692 |
| 9 | Submucous cleft hard palate (HP:0000176) | 4.18825035 |
| 10 | Villous atrophy (HP:0011473) | 4.11921608 |
| 11 | Abnormality of small intestinal villus morphology (HP:0011472) | 4.11921608 |
| 12 | Poor head control (HP:0002421) | 4.03705647 |
| 13 | Alveolar cell carcinoma (HP:0006519) | 3.83064996 |
| 14 | Spinal cord lesions (HP:0100561) | 3.75369644 |
| 15 | Syringomyelia (HP:0003396) | 3.75369644 |
| 16 | Central scotoma (HP:0000603) | 3.73990465 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.72575557 |
| 18 | Skin nodule (HP:0200036) | 3.66569382 |
| 19 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.61753854 |
| 20 | Xanthomatosis (HP:0000991) | 3.54901736 |
| 21 | Congenital stationary night blindness (HP:0007642) | 3.48393017 |
| 22 | Abnormality of the prostate (HP:0008775) | 3.48362960 |
| 23 | Oligomenorrhea (HP:0000876) | 3.42603195 |
| 24 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.42435958 |
| 25 | Flared iliac wings (HP:0002869) | 3.22918331 |
| 26 | Autoimmune hemolytic anemia (HP:0001890) | 3.21234298 |
| 27 | Acute myeloid leukemia (HP:0004808) | 3.19467408 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.15916833 |
| 29 | Absent eyebrow (HP:0002223) | 3.15349219 |
| 30 | Absent eyelashes (HP:0000561) | 3.13322120 |
| 31 | Dyschromatopsia (HP:0007641) | 3.10706523 |
| 32 | Sparse lateral eyebrow (HP:0005338) | 3.10384939 |
| 33 | Thickened helices (HP:0000391) | 2.97068710 |
| 34 | Bulbous nose (HP:0000414) | 2.84849748 |
| 35 | Neoplasm of the lung (HP:0100526) | 2.80976264 |
| 36 | Leukocytosis (HP:0001974) | 2.75678319 |
| 37 | Hypertriglyceridemia (HP:0002155) | 2.74935477 |
| 38 | Abnormality of male internal genitalia (HP:0000022) | 2.68265971 |
| 39 | Progressive microcephaly (HP:0000253) | 2.63307327 |
| 40 | Deep philtrum (HP:0002002) | 2.62401000 |
| 41 | Underdeveloped supraorbital ridges (HP:0009891) | 2.57468421 |
| 42 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 2.55893904 |
| 43 | Pachygyria (HP:0001302) | 2.52445102 |
| 44 | Relative macrocephaly (HP:0004482) | 2.49516607 |
| 45 | Abnormality of the antihelix (HP:0009738) | 2.46423809 |
| 46 | Neoplasm of the respiratory system (HP:0100606) | 2.46227884 |
| 47 | Osteomyelitis (HP:0002754) | 2.45910490 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.41657488 |
| 49 | Impulsivity (HP:0100710) | 2.39057916 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.38004439 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.38004439 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.38004439 |
| 53 | Asymmetry of the thorax (HP:0001555) | 2.36939992 |
| 54 | Flat capital femoral epiphysis (HP:0003370) | 2.35964827 |
| 55 | Short chin (HP:0000331) | 2.35146520 |
| 56 | Type I transferrin isoform profile (HP:0003642) | 2.33465913 |
| 57 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.32298037 |
| 58 | Achilles tendon contracture (HP:0001771) | 2.31025404 |
| 59 | Vasculitis (HP:0002633) | 2.30954891 |
| 60 | Hypercholesterolemia (HP:0003124) | 2.30664621 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.30320493 |
| 62 | Agammaglobulinemia (HP:0004432) | 2.26960868 |
| 63 | Abnormality of the pericardium (HP:0001697) | 2.19003481 |
| 64 | Abnormality of vitamin metabolism (HP:0100508) | 2.18397844 |
| 65 | Complement deficiency (HP:0004431) | 2.13918380 |
| 66 | Abnormality of the Achilles tendon (HP:0005109) | 2.13496132 |
| 67 | Purpura (HP:0000979) | 2.12712091 |
| 68 | Alkalosis (HP:0001948) | 2.12694463 |
| 69 | Cystic hygroma (HP:0000476) | 2.12016751 |
| 70 | Abnormal pupillary function (HP:0007686) | 2.11030294 |
| 71 | Abnormality of B cell number (HP:0010975) | 2.10786447 |
| 72 | Abnormality of complement system (HP:0005339) | 2.08619576 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.06274205 |
| 74 | Polyneuropathy (HP:0001271) | 2.05748736 |
| 75 | Eosinophilia (HP:0001880) | 2.04411285 |
| 76 | Thickened nuchal skin fold (HP:0000474) | 2.02917669 |
| 77 | Lymphoma (HP:0002665) | 2.01875687 |
| 78 | Exercise-induced myalgia (HP:0003738) | 2.00720303 |
| 79 | Erythema (HP:0010783) | 1.98214083 |
| 80 | Skin rash (HP:0000988) | 1.96213091 |
| 81 | Growth hormone excess (HP:0000845) | 1.95283270 |
| 82 | Stomach cancer (HP:0012126) | 1.94801122 |
| 83 | Hematochezia (HP:0002573) | 1.92525891 |
| 84 | Large for gestational age (HP:0001520) | 1.89721245 |
| 85 | Long palpebral fissure (HP:0000637) | 1.87740788 |
| 86 | Recurrent bronchitis (HP:0002837) | 1.87048971 |
| 87 | Ileus (HP:0002595) | 1.86235174 |
| 88 | Agnosia (HP:0010524) | 1.82403784 |
| 89 | Shawl scrotum (HP:0000049) | 1.81431304 |
| 90 | Abnormality of T cell number (HP:0011839) | 1.80241819 |
| 91 | Glomerulonephritis (HP:0000099) | 1.79426702 |
| 92 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79110883 |
| 93 | Generalized hyperpigmentation (HP:0007440) | 1.78761254 |
| 94 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.76739026 |
| 95 | Prominent nose (HP:0000448) | 1.76677265 |
| 96 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.75241803 |
| 97 | Recurrent sinusitis (HP:0011108) | 1.74427656 |
| 98 | Pustule (HP:0200039) | 1.72261216 |
| 99 | Nephritis (HP:0000123) | 1.71799081 |
| 100 | Easy fatigability (HP:0003388) | 1.70970926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 8.51347864 |
| 2 | IRAK4 | 7.72627576 |
| 3 | TAF1 | 6.64196758 |
| 4 | ERN1 | 3.44641609 |
| 5 | ILK | 3.11668038 |
| 6 | PIK3CG | 2.92012989 |
| 7 | BRAF | 2.83809279 |
| 8 | MARK3 | 2.76677517 |
| 9 | KSR1 | 2.51999513 |
| 10 | PTK2 | 2.34207680 |
| 11 | RIPK1 | 2.08755464 |
| 12 | EPHB1 | 2.01204138 |
| 13 | SGK2 | 1.88228162 |
| 14 | EPHA3 | 1.57079427 |
| 15 | MAP2K3 | 1.46541295 |
| 16 | SGK223 | 1.35189876 |
| 17 | SGK494 | 1.35189876 |
| 18 | SGK3 | 1.29236281 |
| 19 | HIPK2 | 1.17227306 |
| 20 | KIT | 1.15658892 |
| 21 | MAP3K11 | 1.15241067 |
| 22 | PRKCI | 1.01178041 |
| 23 | ERBB3 | 1.00376246 |
| 24 | PRPF4B | 0.99506248 |
| 25 | LRRK2 | 0.93352652 |
| 26 | SCYL2 | 0.84067428 |
| 27 | MAP2K6 | 0.83116173 |
| 28 | FGFR4 | 0.82492262 |
| 29 | PIM1 | 0.82468802 |
| 30 | MAPKAPK3 | 0.78946483 |
| 31 | NLK | 0.75730202 |
| 32 | SYK | 0.69617937 |
| 33 | MAP2K4 | 0.60784582 |
| 34 | DAPK1 | 0.58262770 |
| 35 | ABL2 | 0.54519805 |
| 36 | PRKD2 | 0.50927392 |
| 37 | TYK2 | 0.49793216 |
| 38 | HCK | 0.46302063 |
| 39 | CSK | 0.43627448 |
| 40 | FGR | 0.43452356 |
| 41 | JAK1 | 0.36384162 |
| 42 | BTK | 0.36087551 |
| 43 | MST1R | 0.32910040 |
| 44 | TXK | 0.32245596 |
| 45 | BLK | 0.32046849 |
| 46 | FGFR3 | 0.31230371 |
| 47 | IRAK1 | 0.31084471 |
| 48 | JAK3 | 0.30776515 |
| 49 | MAP4K1 | 0.30084959 |
| 50 | STK11 | 0.29640200 |
| 51 | PAK6 | 0.29041700 |
| 52 | FER | 0.28878366 |
| 53 | IKBKE | 0.28841334 |
| 54 | PRKCZ | 0.28013441 |
| 55 | PTK2B | 0.27959518 |
| 56 | PAK1 | 0.26120378 |
| 57 | MET | 0.25653993 |
| 58 | SRC | 0.25390142 |
| 59 | CAMK2B | 0.25258513 |
| 60 | ACVR1B | 0.24923804 |
| 61 | GRK6 | 0.23515970 |
| 62 | TESK2 | 0.23277875 |
| 63 | MAPKAPK2 | 0.22830049 |
| 64 | GSK3A | 0.21917014 |
| 65 | PRKG2 | 0.21722428 |
| 66 | DDR2 | 0.21671105 |
| 67 | MAP2K1 | 0.21097604 |
| 68 | EPHB2 | 0.21013861 |
| 69 | RIPK4 | 0.19870020 |
| 70 | ALK | 0.19746616 |
| 71 | PDGFRB | 0.19466757 |
| 72 | EPHA2 | 0.18174551 |
| 73 | ERBB4 | 0.17927023 |
| 74 | GRK1 | 0.17875979 |
| 75 | LYN | 0.16839891 |
| 76 | INSRR | 0.16748378 |
| 77 | TIE1 | 0.16690369 |
| 78 | CDK9 | 0.15991959 |
| 79 | SGK1 | 0.15184982 |
| 80 | FES | 0.14716160 |
| 81 | CHEK1 | 0.14227089 |
| 82 | PRKCD | 0.13991967 |
| 83 | TGFBR2 | 0.13939034 |
| 84 | CSF1R | 0.13579699 |
| 85 | PRKD1 | 0.12791561 |
| 86 | PTK6 | 0.12671795 |
| 87 | GRK5 | 0.12269374 |
| 88 | ADRBK2 | 0.11863531 |
| 89 | MAPK12 | 0.11259731 |
| 90 | CSNK1E | 0.11201465 |
| 91 | CDC42BPA | 0.11081151 |
| 92 | PDPK1 | 0.11049303 |
| 93 | MATK | 0.09980299 |
| 94 | RET | 0.09935878 |
| 95 | CAMK2G | 0.08996217 |
| 96 | RPS6KA4 | 0.08426934 |
| 97 | MAPK3 | 0.08123609 |
| 98 | PAK3 | 0.07478011 |
| 99 | PIK3CA | 0.07230340 |
| 100 | ZAP70 | 0.06752231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 5.77265817 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.83757308 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.80808738 |
| 4 | Pertussis_Homo sapiens_hsa05133 | 2.63499693 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.63207402 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.38516982 |
| 7 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.38188221 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.19025399 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.15618019 |
| 10 | Thyroid cancer_Homo sapiens_hsa05216 | 2.01009200 |
| 11 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 2.00276633 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.97961959 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94401459 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76092075 |
| 15 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.64802788 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62364387 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.61579892 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.59966194 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59320201 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54261203 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48917442 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46731078 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44170998 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.41307355 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.32190131 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.30893827 |
| 27 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.28248852 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20315796 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18981969 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.18255281 |
| 31 | Hepatitis C_Homo sapiens_hsa05160 | 1.17762716 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.16094101 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11959901 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10778794 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07015677 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03596639 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99205069 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97708126 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 0.97008264 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96089736 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92948229 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90127394 |
| 43 | Measles_Homo sapiens_hsa05162 | 0.89486237 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 0.89280102 |
| 45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85901909 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84514590 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82165046 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73831324 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.70768887 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70759970 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67930746 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67284971 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.65448431 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61579974 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60628421 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59171761 |
| 57 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58630497 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57573723 |
| 59 | Melanoma_Homo sapiens_hsa05218 | 0.57060852 |
| 60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56808039 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55711955 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54233847 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54115708 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.53911306 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53513443 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52825882 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.52627512 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52119843 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50013031 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49621132 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48033286 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47769874 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47394853 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46308683 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45958143 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45561741 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45102113 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45003804 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43874917 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43826976 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43353409 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42778736 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42424337 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42399133 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.41999817 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41931626 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41113617 |
| 88 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40916266 |
| 89 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40885025 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39492218 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37288391 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.37099972 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36513087 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.36375837 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35411552 |
| 96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.35408180 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.34283123 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.32934247 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.32784546 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29989930 |

